- Siponimod in the treatment of multiple sclerosis - a case study2022 | Faculty of Medicine in Hradec Králové
- Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis2022 | Faculty of Medicine in Hradec Králové
- Siponimod for the treatment of adult patients with secondary progressive multiple sclerosis - current experience2021 | Faculty of Medicine in Hradec Králové
- Profile of a patient treated with siponimod in routine clinical practice2021 | Faculty of Medicine in Hradec Králové
- Long‑term effect of siponimod on MRI outcomes in patients with secondary‑progressive multiple sclerosis2022 | Faculty of Medicine in Hradec Králové
- Profile of a patient with secondary progressive MS - how to identify patients that should be sent to a tertiary Center2021 | Second Faculty of Medicine
